American Airlines Group Inc. (ALL) Class Action Lawsuit
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired American Airlines Group Inc. (NASDAQ: AAL) securities between January 25, 2024 and May 28, 2024. American, through wholly-owned subsidiaries and third-party regional carriers under the American Eagle banner, operates as a network air carrier, providing scheduled air transportation passenger and cargo services throughout the US and in various other countries around the world.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating Allegations that American Airlines Group Inc. (AAL) Misled Investors Regarding its Distribution Strategy
The complaint alleges that during the class period defendants misrepresented the true state of the Company, namely, that the Company’s sales and distribution strategy was not driving the revenue projected. Instead, it was driving customers away as the strategy and its attested poor execution made it more difficult for customers to access the Company’s services.
The truth emerged after-market on May 28, 2024, when American reported the prompt termination of its Executive Vice President and Chief Commercial Officer, Vasu S. Raja, along with an abrupt reduction in its short-term guidance. During a conference presentation on May 29, 2024, the Company attributed its lowered guidance to a softness in consumer bookings, a domestic supply and demand imbalance, and a reduction in capacity growth. In pertinent part, Defendants announced that the reduced consumer bookings were significantly due to the changes American made to their sales and distribution strategy, that they did not execute their strategy properly, and that they will now be modifying their strategy in an attempt to recapture the customers their strategy drove away. As a result, Defendants reduced their second quarter fiscal year 2024 projections, notably cutting their projections for the Company’s operating margin by a full percentage point and adjusted earnings per share for the quarter by more than 17%. On this news, the price of American’s common stock declined from a closing market price of $13.44 per share on May 28, 2024, to $11.62 per share on May 29, 2024, a decline of more than 13.5%.
What Now: You may be eligible to participate in the class action against American Airlines Group Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by September 16, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.
To be notified if a class action against American Airlines Group Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
| Contact: Aaron Dumas, Jr. Robbins LLP 5060 Shoreham Pl., Ste. 300 San Diego, CA 92122 adumas@robbinsllp.com (800) 350-6003 www.robbinsllp.com | https://www.facebook.com/RobbinsLLP/ https://www.linkedin.com/company/robbins-llp/ |
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cdb02be0-49fb-4d47-8011-0a90eee9a931
- Hillman Reports First Quarter 2025 Results - April 29, 2025
- Repligen Reports First Quarter 2025 Financial Results - April 29, 2025
- Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution - April 29, 2025
